-
Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
-
An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
-
An investigation into the specific function of the vaccinia virus :13.8 kDa protein encoded by the N1L gene
-
In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
-
Delivery of Vaccinia Virus Complement Control Protein (VCP) and Curcumin to the rodents' brain : implications in Alzheimer's disease and HIV dementia
-
Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein
-
Cloning and expression of a functionally active truncated N-glycosylated KSHV complement regulatory protein and immunohistochemical studies with the anti-KCP peptide antibody
-
Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine
-
A comparative analysis of cowpox virus (CPV WT) and a deletion mutant lacking the gene encoding the inflammation modulatory protein (CPV IMP)
-
Adaptive changes in HIV-1 subtype c proteins during early infection and their effect on disease progression
-
An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
-
The investigation of histopathological changes after the administration of vaccinia virus complement control protein in brain injured rats
-
Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
-
Prokaryotic Production of Human Immunodeficiency VirusType 1 Subtype C Tat, Nef and Reverse Transcriptase andInvestigation of Antibody Responses to these proteins inHIV-1 Infected Individuals as well as Macaques Vaccinatedwith SAAVI DNA-C/C2 and SAAV
-
Characterization of genotypic and phenotypic properties of transmitted Human Immunodeficiency virus type 1 variants circulating in Mbeya Tanzania
-
Genetic characterisation of six novel African swine fever viruses isolated from a pig, warthog, wild boar, and ticks
-
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
-
A study of host genetic determinants of human papillomavirus (HPV) infection, cervical cancer and herpes simplex virus type-2 (HSV-2) infection
-
Investigation of viral causes of undiagnosed neurological disease in animals and their zoonotic risk to humans in South Africa
-
Impact of Cytotoxic T Lymphocyte (CTL) escape mutations in acute/Early HIV-1 Subtype C Infection on Disease Progression
-
Impact of long-acting contraceptives on female genital tract cytokine profiles in a randomised controlled trial
-
A study of the host-restricted lumpy skin disease virus as a vaccine vector using rabies babies virus as a model
-
A study of HIV-1 dual infection in a cohort of subtype C infected sex workers : viral evolution and its association with disease progression
-
Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
